TY - JOUR
T1 - 2007 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN)
AU - Colbert, Robert A.
AU - Deodhar, Atul A.
AU - Khan, Muhammad Asim
AU - Lories, Rik J.
AU - Maksymowych, Walter P.
AU - Reveille, John D.
AU - Ritchlin, Christopher T.
AU - Rosenbaum, James T.
AU - Targan, Stephan R.
AU - Weisman, Michael
AU - Clegg, Daniel O.
N1 - Copyright:
Copyright 2009 Elsevier B.V., All rights reserved.
PY - 2008/7
Y1 - 2008/7
N2 - The Spondylarthritis Research and Therapy Network (SPARTAN; www.spartangroup.org) was founded in 2003 by a group of North American clinicians and researchers to promote research, education, and treatment of spondyloarthritis (SpA). In past years, it has produced and disseminated United States-specific modifications of the ASsessments in Ankylosing Spondylitis (ASAS) guidelines for the use of anti-tumor necrosis factor (TNF) therapy in AS1,2. SPARTAN held its fifth annual research meeting in September 2007 in Cleveland, Ohio. Highlights of the meeting included updates on current research in SpA, including epidemiology and genetics, bone formation and inflammation, biomarkers, activation of the IL-23/IL-17 axis, and animal models. A presentation was made on basic and clinical science of inflammatory bowel disease, and an educational pre-meeting conference was specifically designed for rheumatology fellows.
AB - The Spondylarthritis Research and Therapy Network (SPARTAN; www.spartangroup.org) was founded in 2003 by a group of North American clinicians and researchers to promote research, education, and treatment of spondyloarthritis (SpA). In past years, it has produced and disseminated United States-specific modifications of the ASsessments in Ankylosing Spondylitis (ASAS) guidelines for the use of anti-tumor necrosis factor (TNF) therapy in AS1,2. SPARTAN held its fifth annual research meeting in September 2007 in Cleveland, Ohio. Highlights of the meeting included updates on current research in SpA, including epidemiology and genetics, bone formation and inflammation, biomarkers, activation of the IL-23/IL-17 axis, and animal models. A presentation was made on basic and clinical science of inflammatory bowel disease, and an educational pre-meeting conference was specifically designed for rheumatology fellows.
UR - http://www.scopus.com/inward/record.url?scp=47349096817&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=47349096817&partnerID=8YFLogxK
M3 - Article
C2 - 18484685
AN - SCOPUS:47349096817
SN - 0315-162X
VL - 35
SP - 1398
EP - 1402
JO - Journal of Rheumatology
JF - Journal of Rheumatology
IS - 7
ER -